Clinical trial
The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis…
NCT00092118 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092118 |
|---|---|
| Title | The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) |
| Official title | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | Montelukast, Comparator: Placebo |
| Enrollment | 1,992 |
| Start date | Oct 1, 2003 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Sep 24, 2004 |
| Last update posted | Feb 3, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: